Brief: H Lundbeck Explores New Area In Neurohormonal Dysfunctions
June 19 (Reuters) - H Lundbeck A/S HLUNb.CO :
* EXPLORES NEW AREA IN NEUROHORMONAL DYSFUNCTIONS BY
INITIATING
PHASE II TRIAL USING LU AG13909 AS POTENTIAL TREATMENT FOR
CUSHING'S DISEASE
Source text for Eikon: ID:nWkr2s4XZp
Further company coverage: HLUNb.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on H Lundbeck A/S
See all newsUBS upgrades Lundbeck to 'buy' on high epilepsy drug conviction
DB downgrades Lundbeck to 'sell' on Rexulti patent cliff risk
Europe Research Roundup: ASM International, Michelin, Nokian Renkaat
Europe Research Roundup: BAWAG Group, Enka Insaat, Partners Group Holding
Europe Research Roundup: BMW, Fugro, Mercedes-Benz